ホーム › 卵巣がん › ニュージャージー › Edison
Edison、NJにおける卵巣がんの臨床試験
Edisonとその周辺地域（約30マイル以内）の拠点で、卵巣がんに関する20件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
被験者募集中第2/3相
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3マイル先
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15マイル先
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
被験者募集中第2相
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3マイル先
- Robert Wood Johnson University Hospital Somerset, Somerville · 11マイル先
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
被験者募集中第1相
- START New Jersey, East Brunswick · 6マイル先
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
被験者募集中第1相
- Research Site, New Brunswick · 3マイル先
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
被験者募集中第2相
- Rutgers Cancer Institute of New Jersey /ID# 274358, New Brunswick · 3マイル先
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
被験者募集中第2相
- Research Site, East Brunswick · 6マイル先
A Study of Isoquercetin in People With Ovarian Cancer
被験者募集中第2相
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · 15マイル先
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
被験者募集中観察研究
- Astera Cancer Care, East Brunswick · 6マイル先
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
被験者募集中第1/2相
- START New Jersey East Brunswick, East Brunswick · 6マイル先
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
被験者募集中第1相
- START - New Jersey, East Brunswick · 6マイル先
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
被験者募集中第3相
- Rutgers Cancer Institute of New Jersey ( Site 0071), New Brunswick · 3マイル先
Study of TUB-040 Given With Standard Ovarian Cancer Drugs in Patients With Fast-growing Ovarian Cancer
被験者募集中第1/2相
- Start Njeb, East Brunswick · 6マイル先
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
被験者募集中
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3マイル先
- Virtua Voorhees, Voorhees Township · 5マイル先
- Robert Wood Johnson University Hospital Somerset, Somerville · 11マイル先
- 他1件
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
被験者募集中第3相
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3マイル先
- Robert Wood Johnson University Hospital Somerset, Somerville · 11マイル先
- Summit Medical Group, Berkeley Heights · 11マイル先
- 他1件
A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE)
被験者募集中
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15マイル先
Study of Acute Normovolemic Hemodilution (ANH) in People With Ovarian Cancer Who Are Having Cytoreductive Surgery
被験者募集中第2相
- Memoral Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · 15マイル先
A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer
被験者募集中第1相
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15マイル先
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
被験者募集中第2相
- Rutgers Cancer Institute, New Brunswick · 3マイル先
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
被験者募集中観察研究
- Massive Bio SYNERGY-AI site, New Brunswick · 3マイル先
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
被験者募集中第1相
- Exelixis Clinical Site #9, New Brunswick · 3マイル先
他の都市における卵巣がんの試験
- Houston, TX89件の研究
- New York City, NY69件の研究
- Boston, MA61件の研究
- Los Angeles, CA50件の研究
- Nashville, TN49件の研究
- Arlington, VA46件の研究
- Philadelphia, PA44件の研究
- Columbus, OH39件の研究
- St. Louis, MO38件の研究
- Chicago, IL36件の研究
- San Antonio, TX31件の研究
- Cleveland, OH30件の研究
Edisonにおける他の研究
- 乳がん68件の研究
- 非小細胞肺癌47件の研究
- がん（全種類）33件の研究
- 前立腺がん29件の研究
- 大腸癌23件の研究
- 肺がん23件の研究
- 多発性骨髄腫22件の研究
- 膀胱癌21件の研究
- 急性骨髄性白血病20件の研究
- 転移性癌20件の研究
- 子宮内膜がん19件の研究
- 尿路上皮（移行上皮）癌18件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。